Trial Profile
A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka [trandolapril/verapamil] and Hyzaar [losartan/hydrochlorothiazide] on Glucose Tolerance in Subjects With Metabolic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Verapamil/trandolapril (Primary) ; Losartan/hydrochlorothiazide
- Indications Diabetes mellitus; Metabolic syndrome
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms STAR
- Sponsors Abbott Laboratories
- 16 Aug 2008 New trial record.